Geneva Capital Management LLC Acquires 146,778 Shares of Exponent, Inc. (NASDAQ:EXPO)

Geneva Capital Management LLC boosted its holdings in Exponent, Inc. (NASDAQ:EXPO) by 10.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,558,189 shares of the business services provider’s stock after purchasing an additional 146,778 shares during the quarter. Exponent makes up 2.6% of Geneva Capital Management LLC’s portfolio, making the stock its 4th biggest holding. Geneva Capital Management LLC’s holdings in Exponent were worth $137,183,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in EXPO. Operose Advisors LLC acquired a new stake in shares of Exponent in the third quarter worth approximately $39,000. Signaturefd LLC increased its stake in Exponent by 157.7% during the third quarter. Signaturefd LLC now owns 915 shares of the business services provider’s stock worth $78,000 after acquiring an additional 560 shares during the last quarter. Parkside Financial Bank & Trust lifted its stake in shares of Exponent by 10.5% in the 3rd quarter. Parkside Financial Bank & Trust now owns 1,468 shares of the business services provider’s stock valued at $126,000 after purchasing an additional 140 shares in the last quarter. Covestor Ltd grew its holdings in shares of Exponent by 24.8% during the 3rd quarter. Covestor Ltd now owns 1,474 shares of the business services provider’s stock worth $126,000 after purchasing an additional 293 shares during the period. Finally, Quadrature Capital Ltd increased its position in shares of Exponent by 6.7% in the third quarter. Quadrature Capital Ltd now owns 2,452 shares of the business services provider’s stock worth $210,000 after acquiring an additional 155 shares in the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Stock Up 0.4 %

Shares of EXPO traded up $0.41 during trading on Thursday, reaching $94.46. The company’s stock had a trading volume of 279,375 shares, compared to its average volume of 310,985. Exponent, Inc. has a twelve month low of $64.61 and a twelve month high of $102.72. The company has a market cap of $4.78 billion, a price-to-earnings ratio of 47.71 and a beta of 0.64. The company has a fifty day moving average of $82.39 and a two-hundred day moving average of $82.15.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.13. The company had revenue of $137.21 million for the quarter, compared to the consensus estimate of $125.98 million. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same period last year, the firm posted $0.56 EPS. As a group, equities analysts forecast that Exponent, Inc. will post 1.92 EPS for the current fiscal year.

Exponent Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be paid a $0.28 dividend. The ex-dividend date is Friday, June 7th. This represents a $1.12 annualized dividend and a dividend yield of 1.19%. Exponent’s payout ratio is 56.57%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on EXPO. StockNews.com raised Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Truist Financial lifted their price objective on shares of Exponent from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, April 29th.

Insider Buying and Selling at Exponent

In other Exponent news, VP Bradley A. James sold 3,528 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $95.00, for a total value of $335,160.00. Following the transaction, the vice president now owns 2,030 shares of the company’s stock, valued at $192,850. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, VP Bradley A. James sold 3,528 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $95.00, for a total value of $335,160.00. Following the completion of the sale, the vice president now directly owns 2,030 shares of the company’s stock, valued at $192,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Eric Guyer sold 3,367 shares of Exponent stock in a transaction on Friday, February 9th. The shares were sold at an average price of $78.49, for a total transaction of $264,275.83. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,558 shares of company stock valued at $753,402. Company insiders own 2.20% of the company’s stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.